版本:
中国

BRIEF-Otsuka announces results of phase 3 data on tolvaptan

May 22 Otsuka Holdings Co Ltd

* Otsuka announces results of phase 3 data on tolvaptan

* Says primary and key secondary endpoints were positive for tolvaptan versus placebo in an additional phase 3 clinical trial

* Data are intended to address complete response letter issued by FDA for a new drug application for tolvaptan in ADPKD in 2013

* Says there were no new safety issues identified for tolvaptan during trial Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐